Skip to main content
. 2019 Oct 28;7:165. doi: 10.1186/s40478-019-0824-1

Fig. 2.

Fig. 2

Comparison of the mean density of pTDP-43 aggregates among patients with ALS, neuromuscular diseases and non-neuromuscular diseases (a). Comparison among patients with ALS types 1 and 2, neuromuscular diseases and non-neuromuscular diseases (b)